Russ Johannesson, CEO, Glooko
Russ Johannesson has been CEO of Glooko since 2018. In that time the diabetes data platform has expanded internationally, made a couple of acquisitions, and added support for digital therapeutics and distributed clinical trials. He brought me up to date with the latest–Matthew Holt
Source: The Health Care Blog - Category: Consumer Health News Authors: matthew holt Tags: Matthew Holt THCB Spotlights Glooko Russ Johannesson Source Type: blogs
More News: Blogging | Clinical Trials | Diabetes | Endocrinology | Health | Health Management | Information Technology | Mergers and Aquisitions